Citation Impact
Citing Papers
Complement and microglia mediate early synapse loss in Alzheimer mouse models
2016 StandoutScience
Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
2013
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
2011 Standout
Is there a future for vaccination as a treatment for Alzheimer's disease?
2003
Memantine in Moderate-to-Severe Alzheimer's Disease
2003 Standout
Plasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort study
2006
Advances in the development of biomarkers for Alzheimer’s disease: from CSF total tau and Aβ1–42 proteins to phosphorylated tau protein
2003
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Cerebrospinal fluid protein biomarkers for Alzheimer’s disease
2004
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
2007 Standout
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Decreased cerebrospinal fluid Aβ 42 correlates with brain atrophy in cognitively normal elderly
2009
Alzheimer's disease
2011 Standout
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis
1998
CSF markers for incipient Alzheimer's disease
2003
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
2002 StandoutNature
Decreased β-Amyloid1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease
2003
Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease
2009
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study
1998
CSF Biomarkers for Alzheimer’s Disease: Levels of β-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival
2006
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Diagnosis of Alzheimer's Disease
1997
Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease
2000
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
2004 Standout
Non-alcoholic fatty liver disease
2021 Standout
Combination of the different biological markers for increasing specificity of in vivo Alzheimer’s testing
1998
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
Dynamic Analysis of Amyloid β-Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal Aβ during Age-Related Plaque Formation
2011
Questionable Dementia: Clinical Course and Predictors of Outcome
1997
Plasma β‐Amyloid Peptide, Transforming Growth Factor‐β1, and Risk for Cerebral Amyloid Angiopathy
2000
Alzheimer's disease
2006 Standout
Alzheimer's disease
2016 Standout
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles
2003 Standout
Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation
2006 Standout
Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trial
2002
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
2001
Alzheimer's Disease
2010 Standout
HbA1c 5·7–6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study
2011
CSF biomarkers for mild cognitive impairment and early Alzheimer's disease
2004
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
2005 Standout
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.
2000 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability
2002 Standout
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation
2011 StandoutNatureNobel
Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats
2007
Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes
2014
Amyloid biomarkers in Alzheimer's disease
2015
Neurodegenerative diseases and oxidative stress
2004 Standout
Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
1999
Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
2009
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
2019 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy
1998
The molecular pathology of Alzheimer's disease
1991 Standout
Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers
2006
The amyloid precursor protein of Alzheimer’s disease and the Aβ peptide
1999
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta‐analysis of the LEAD program
2012
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample
1999
Pilot study of liraglutide effects in non‐alcoholic steatohepatitis and non‐alcoholic fatty liver disease with glucose intolerance in J apanese patients (LEAN ‐J )
2014
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
2012
Effects of Simvastatin on Cerebrospinal Fluid Biomarkers and Cognition in Middle-Aged Adults at Risk for Alzheimer's Disease
2008
Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum
2016
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
Alzheimer's disease: a re-examination of the amyloid hypothesis
1998
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Cardiovascular Biology of the Incretin System
2012
Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care
2018
Recommendations for Prevention of Childhood Obesity
2007
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
New ELISAs with high specificity for soluble oligomers of amyloid β‐protein detect natural Aβ oligomers in human brain but not CSF
2013
Three-Dimensional Structure of an Independently Folded Extracellular Domain of Human Amyloid-β Precursor Protein,
2004 StandoutNobel
The Calpain System
2003 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
1999
Lipotoxicity and the gut-liver axis in NASH pathogenesis
2017
Alzheimer's Disease: Genes, Proteins, and Therapy
2001 Standout
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions
2016 Standout
Alzheimer's Disease Is a Synaptic Failure
2002 StandoutScience
A water-soluble metal–organic complex array as a multinuclear heterometallic peptide amphiphile that shows unconventional anion dependency in its self-assembly
2015 StandoutNobel
Plasma tau in Alzheimer disease
2016 StandoutNobel
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
2015
Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease
2001
High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
2000 Standout
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Biological Markers in Alzheimer Disease
2002
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis
2003 StandoutScience
Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease
2014
APOE ε4 allele is associated with reduced cerebrospinal fluid levels of Aβ42
2004
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
2001
Works of Darin E. Olson being referenced
Weight loss and incidence of diabetes with the Veterans Health Administration MOVE! lifestyle change programme: an observational study
2015
Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats
2005
Implementing evidence-based diabetes care in geriatric populations. The chronic care model.
2004
Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
2011
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet
2011
Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
1995
Hospital Discharge Algorithm Based on Admission HbA1c for the Management of Patients With Type 2 Diabetes
2014
Screening for Diabetes and Pre-Diabetes With Proposed A1C-Based Diagnostic Criteria
2010
Screening for Diabetes and Prediabetes With Proposed A1C-Based Diagnostic Criteria
2010